Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adult human mesenchymal stem cells for steroid-refractory acute graft-versus-host disease
IRCT2014072618603N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of human mesenchymal stem cells in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Shiraz University of Medical Sciences. Started Apr 2016; status: completed.
02
Drugs
human mesenchymal stem cells
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on IRCT2014072618603N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014072618603N1.